Invention Grant
- Patent Title: Depletion of host cell components from live vector vaccines
- Patent Title (中): 从活载体疫苗中消耗宿主细胞成分
-
Application No.: US13988986Application Date: 2011-11-23
-
Publication No.: US09273289B2Publication Date: 2016-03-01
- Inventor: Ingo Jordan , Holger Bernhardt , Stefan Hartmann
- Applicant: Ingo Jordan , Holger Bernhardt , Stefan Hartmann
- Applicant Address: DE Berlin
- Assignee: PROBIOGEN AG
- Current Assignee: PROBIOGEN AG
- Current Assignee Address: DE Berlin
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- International Application: PCT/EP2011/005901 WO 20111123
- International Announcement: WO2012/069190 WO 20120531
- Main IPC: C12N7/02
- IPC: C12N7/02

Abstract:
It is desirable to produce live vaccines, which are highly attenuated and which do only contain minimal or no animal-derived components. The production of highly attenuated live viruses can be better achieved when using specifically designed cell lines as producer substrate as opposed to using less defined primary cells. However, live viruses, thus produced comprise undesirable components from the cell lines and cell culture. The present invention relates to methods of production and purification of live enveloped viruses, which are suitable for vaccination.
Public/Granted literature
- US20130273636A1 DEPLETION OF HOST CELL COMPONENTS FROM LIVE VECTOR VACCINES Public/Granted day:2013-10-17
Information query